loadpatents
name:-0.03242015838623
name:-0.010442018508911
name:-0.0050859451293945
Kwon; Eugene D. Patent Filings

Kwon; Eugene D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kwon; Eugene D..The latest application filed is for "costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target".

Company Profile
4.11.31
  • Kwon; Eugene D. - Rochester MN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
Grant 11,242,387 - Chen , et al. February 8, 2
2022-02-08
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
App 20210380690 - Chen; Lieping ;   et al.
2021-12-09
Methods for treating cancer in patients with elevated levels of Bim
Grant 11,136,393 - Dong , et al. October 5, 2
2021-10-05
Soluble B7-H1
App 20200326344 - Kwon; Eugene D. ;   et al.
2020-10-15
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
App 20200002419 - Chen; Lieping ;   et al.
2020-01-02
Methods For Treating Cancer In Patients With Elevated Levels Of Bim
App 20190315869 - Dong; Haidong ;   et al.
2019-10-17
Methods for treating cancer in patients with elevated levels of BIM
Grant 10,259,875 - Dong , et al.
2019-04-16
Methods and materials for treating cancer
Grant 10,167,336 - Dong , et al. J
2019-01-01
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
App 20180179281 - Chen; Lieping ;   et al.
2018-06-28
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
App 20180100015 - Chen; Lieping ;   et al.
2018-04-12
Soluble B7-H1
App 20170363634 - Kwon; Eugene D. ;   et al.
2017-12-21
Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
Grant 9,803,015 - Chen , et al. October 31, 2
2017-10-31
B7-h3 In Cancer
App 20170146539 - Kwon; Eugene D. ;   et al.
2017-05-25
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
App 20160264667 - Chen; Lieping ;   et al.
2016-09-15
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
App 20160257953 - Chen; Lieping ;   et al.
2016-09-08
Methods For Treating Cancer In Patients With Elevated Levels Of Bim
App 20160251437 - Dong; Haidong ;   et al.
2016-09-01
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
App 20160245816 - Chen; Lieping ;   et al.
2016-08-25
Methods And Materials For Treating Cancer
App 20160176967 - Dong; Haidong ;   et al.
2016-06-23
B7-h1 And B7-h4 In Cancer
App 20160153996 - Kwon; Eugene D. ;   et al.
2016-06-02
B7-h1 And Survivin In Cancer
App 20160154000 - Kwon; Eugene D. ;   et al.
2016-06-02
Methods and materials for treating cancer
Grant 9,302,005 - Dong , et al. April 5, 2
2016-04-05
B7-h4 Expression On Tumor Vasculature
App 20160051675 - Kwon; Eugene D. ;   et al.
2016-02-25
B7-H4 expression on tumor vasculature
Grant 9,121,853 - Kwon , et al. September 1, 2
2015-09-01
Soluble B7-H1
App 20150111232 - Kwon; Eugene D. ;   et al.
2015-04-23
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
App 20150044165 - CHEN; Lieping ;   et al.
2015-02-12
B7-h1 And B7-h4 In Cancer
App 20140335541 - Kwon; Eugene D. ;   et al.
2014-11-13
B7-h1 And Survivin In Cancer
App 20140329248 - Kwon; Eugene D. ;   et al.
2014-11-06
Methods And Materials For Treating Cancer
App 20140271674 - Dong; Haidong ;   et al.
2014-09-18
B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
Grant 8,747,833 - Chen , et al. June 10, 2
2014-06-10
Methods For Reducing Granulomatous Inflammation
App 20130251736 - Kwon; Eugene D. ;   et al.
2013-09-26
B7-h3 In Cancer
App 20130122021 - Kwon; Eugene D. ;   et al.
2013-05-16
B7-h1 And Methods Of Diagnosis, Prognosis, And Treatment Of Cancer
App 20110200620 - CHEN; Lieping ;   et al.
2011-08-18
B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
Grant 7,892,540 - Chen , et al. February 22, 2
2011-02-22
Methods For Reducing Granulomatous Inflammation
App 20110020325 - Kwon; Eugene D. ;   et al.
2011-01-27
B7-h3 In Cancer
App 20100203035 - Kwon; Eugene D. ;   et al.
2010-08-12
B7-h1 And Survivin In Cancer
App 20100015642 - Kwon; Eugene D. ;   et al.
2010-01-21
B7-h1 And B7-h4 In Cancer
App 20090215084 - Kwon; Eugene D. ;   et al.
2009-08-27
Soluble B7-H1
App 20090176317 - Kwon; Eugene D. ;   et al.
2009-07-09
B7-h4 Expression On Tumor Vasculature
App 20070218032 - Kwon; Eugene D. ;   et al.
2007-09-20
B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
App 20060083744 - Chen; Lieping ;   et al.
2006-04-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed